PT736029E - Sulfamatos de pseudofructopiranose anticonvulsivos - Google Patents

Sulfamatos de pseudofructopiranose anticonvulsivos

Info

Publication number
PT736029E
PT736029E PT95904333T PT95904333T PT736029E PT 736029 E PT736029 E PT 736029E PT 95904333 T PT95904333 T PT 95904333T PT 95904333 T PT95904333 T PT 95904333T PT 736029 E PT736029 E PT 736029E
Authority
PT
Portugal
Prior art keywords
sulfamatos
pseudofructopiranosis
anticonvulsivos
disclosed
compound
Prior art date
Application number
PT95904333T
Other languages
English (en)
Inventor
Michael J Costanzo
Bruce E Maryanoff
David F Mccomsey
Samuel O Nortey
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/337,597 external-priority patent/US5498629A/en
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of PT736029E publication Critical patent/PT736029E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Confectionery (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
PT95904333T 1993-12-23 1994-12-15 Sulfamatos de pseudofructopiranose anticonvulsivos PT736029E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17339993A 1993-12-23 1993-12-23
US08/337,597 US5498629A (en) 1993-12-23 1994-11-10 Anticonvulsant pseudofructopyranose sulfamates

Publications (1)

Publication Number Publication Date
PT736029E true PT736029E (pt) 2006-05-31

Family

ID=26869093

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95904333T PT736029E (pt) 1993-12-23 1994-12-15 Sulfamatos de pseudofructopiranose anticonvulsivos

Country Status (13)

Country Link
EP (1) EP0736029B1 (pt)
JP (1) JP3555032B2 (pt)
AT (1) ATE319715T1 (pt)
AU (1) AU695336B2 (pt)
CA (1) CA2179733C (pt)
DE (1) DE69434652T2 (pt)
DK (1) DK0736029T3 (pt)
ES (1) ES2260761T3 (pt)
IL (1) IL112098A (pt)
NZ (1) NZ277725A (pt)
PT (1) PT736029E (pt)
RU (1) RU2139875C1 (pt)
WO (1) WO1995017406A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061138A1 (en) * 1999-04-08 2000-10-19 Ortho-Mcneil Pharmaceutical, Inc. Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
JP2003505465A (ja) 1999-07-26 2003-02-12 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 急性虚血により引き起こされる神経変性の処置において有用な三環式単糖誘導体
DK1471871T3 (da) * 2001-02-02 2007-09-17 Ortho Mcneil Pharm Inc Behandling af neurologisk dysfunktion omfattende fructopyranosesulfamater og erytropoietin
WO2003039563A1 (en) * 2001-11-06 2003-05-15 Ortho-Mcneil Pharmaceutical Inc. Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
US7060725B2 (en) * 2002-05-13 2006-06-13 Janssen Pharmaceutica N.V. Substituted sulfamate anticonvulsant derivatives
MY147767A (en) 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
JP2008545650A (ja) 2005-05-20 2008-12-18 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ スルファミド誘導体の製造方法
US8691867B2 (en) 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8497298B2 (en) 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
US8492431B2 (en) 2005-12-19 2013-07-23 Janssen Pharmaceutica, N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
US8716231B2 (en) 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
EP2026790A2 (en) 2006-05-19 2009-02-25 Janssen Pharmaceutica, N.V. Co-therapy for the treatment of epilepsy and related disorders
US8809385B2 (en) 2008-06-23 2014-08-19 Janssen Pharmaceutica Nv Crystalline form of (2S)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide
US8815939B2 (en) 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
WO2015088271A1 (en) * 2013-12-12 2015-06-18 Bio-Pharm Solutions, Co., Ltd. Sulfamate derivative compound for use in preventing or treating epilepsy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997585A (en) * 1974-12-30 1976-12-14 Ortho Pharmaceutical Corporation Aliphatic sulfamates
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4792569A (en) * 1987-08-27 1988-12-20 Mcneilab, Inc. Anticonvulsant phenethyl sulfamates
US5242942A (en) * 1992-04-28 1993-09-07 Mcneilab, Inc. Anticonvulsant fructopyranose cyclic sulfites and sulfates

Also Published As

Publication number Publication date
EP0736029B1 (en) 2006-03-08
AU695336B2 (en) 1998-08-13
IL112098A0 (en) 1995-03-15
NZ277725A (en) 1998-04-27
AU1306795A (en) 1995-07-10
DE69434652D1 (de) 2006-05-04
DK0736029T3 (da) 2006-05-15
JP3555032B2 (ja) 2004-08-18
JPH09507070A (ja) 1997-07-15
CA2179733A1 (en) 1995-06-29
DE69434652T2 (de) 2007-03-01
EP0736029A1 (en) 1996-10-09
RU2139875C1 (ru) 1999-10-20
WO1995017406A1 (en) 1995-06-29
ATE319715T1 (de) 2006-03-15
IL112098A (en) 1997-07-13
ES2260761T3 (es) 2006-11-01
CA2179733C (en) 2007-03-27

Similar Documents

Publication Publication Date Title
PT736029E (pt) Sulfamatos de pseudofructopiranose anticonvulsivos
ATE306261T1 (de) Antithrombosemittel
IL123293A (en) Piperidine derivatives, their preparation and pharmaceutical compositions containing them
IL133623A0 (en) Antithrombotic agents
CA2216796A1 (en) Quinazoline derivatives
EA199600104A1 (ru) Повышенная биодоступность биологически активных соединений при связывании с производными полипирролкарбоксамидонафталиновой кислоты
SE9504661D0 (sv) New compounds
MX9708696A (es) Cefalosporinas antibacterianas.
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
MX9708452A (es) Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma.
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
HUP9701660A2 (hu) 10,13,15-trioxa-triciklo[9.2.1.1. 9.6]pentadekanon-származékok, eljárás ezek előállítására, és az e vegyületeket tartalmazó gyógyászati készítmények
NO980296L (no) Forbedrede terapeutiske midler
BG101605A (bg) Ентерокинетични бензамиди
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
ZA979647B (en) Heterocyclic compounds, compositions and uses.
IT1270905B (it) Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
SE9504662D0 (sv) New compounds
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ZA979650B (en) Heterocyclic compounds, compositions and uses.
ZA979645B (en) Heterocyclic compounds, compositions and uses.
ES2162986T3 (es) Derivados de mercapto-alcanoil-dipeptidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE9203824D0 (sv) Benzofuranylimidazole derivatives a process for the preparation and therapeutical compositions containing the same